Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Two China Pharma Plays
TheStreet.com
Thursday, December 10, 2009 - 11:01am
tags:
China, Tianyin Pharmaceutical, Biostar Pharmaceuticals
Solvay's Alleged Off-Label Switcheroo: 2 Legit Indications Reversed
BNET Pharma
Thursday, December 10, 2009 - 11:00am
tags:
Solvay, off-label, Marinol
Ranbaxy: Generic Version of Flomax to Be Launched in March
WSJ Online
Thursday, December 10, 2009 - 10:43am
tags:
Flomax, generics, India, Ranbaxy, Astellas
Glaxo plans to beat rivals in emerging markets
Yahoo/AP
Thursday, December 10, 2009 - 10:37am
tags:
GSK, emerging markets
Drug costs doubled in one decade
Fierce Pharma
Thursday, December 10, 2009 - 10:31am
tags:
drug costs
All Eyes on Cel-Sci: Will Wednesday's Surge Continue?
Seeking Alpha
Thursday, December 10, 2009 - 10:31am
tags:
Cel-Sci
Facet rejects Biogen Idec offer
Bizjournals.com
Thursday, December 10, 2009 - 10:30am
tags:
Facet Biotech, M&A, Biogen Idec
Drugmakers, Hospitals, Insurers Fight Changes to Health Bill
Bloomberg
Thursday, December 10, 2009 - 10:27am
tags:
healthcare bill, healthcare reform
How Gloucester Achieved the Impossible Even Before Inking the Celgene Deal
BNET Pharma
Thursday, December 10, 2009 - 10:26am
tags:
Celgene, Glouchester Pharma, M&A
Dendreon's New Stock Offering Takes Advantage of Provenge Decision Uncertainty
BNET Pharma
Thursday, December 10, 2009 - 10:25am
tags:
Provenge, Dendreon, stock offering
FDA Complete Response Letters & Transparency
Pharmalot
Thursday, December 10, 2009 - 10:24am
tags:
FDA, transparency
Lilly forecasts sidestep 2011-2014 patent cliff
Yahoo/Reuters
Thursday, December 10, 2009 - 8:56am
tags:
patents, Eli Lilly, earnings
AstraZeneca Explores Drugmaker Alliances to Spread Cost, Risks
Bloomberg
Thursday, December 10, 2009 - 8:44am
tags:
AstraZeneca, drug development, partnerships
SEC eyes 9 deals in insider trading probe: report
Yahoo/Reuters
Thursday, December 10, 2009 - 8:36am
tags:
Wyeth, SEC, Schering Plough, Pfizer, Merck, M&A, Eli Lilly, insider trading, Abbott Laboratories
Major Surgery at Sanofi
Businessweek
Thursday, December 10, 2009 - 8:34am
tags:
Sanofi, Chris Viehbacher, Pharma CEOs, M&A
Lilly Plans Two New Drugs a Year Starting in 2013, China Focus
Bloomberg
Thursday, December 10, 2009 - 7:54am
tags:
China, Eli Lilly, pipelines, Alzheimer's disease, diabetes, cancer
High Hopes Remain for Celgene's Revlimid
Seeking Alpha
Thursday, December 10, 2009 - 7:53am
tags:
Celgene, Revlimid, Multiple Myeloma
H1N1 Vaccines Finally Bearing Revenue
Investopedia
Thursday, December 10, 2009 - 7:40am
tags:
vaccines, swine flu, H1N1, Baxter International, GSK, Sanofi, Novartis, AstraZeneca
Pfizer rises as analyst expects dividend increase
Yahoo/AP
Thursday, December 10, 2009 - 7:40am
tags:
Pfizer, dividends
Watson Acquires Arrow
Yahoo/Zacks.com
Thursday, December 10, 2009 - 7:38am
tags:
Watson Pharmaceuticals, Arrow, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.